
Herbalife comes into this refinancing with its shares at $19.28 and a mixed return profile. The stock is up 50.4% year to date and 133.4% over the past year, while the 3 year and 5 year returns are a 5.8% decline and a 57.9% decline respectively. That backdrop helps explain why investors are likely to focus on how this debt move and operating update fit together.
The refinancing could influence Herbalife’s future financial flexibility and the balance between debt and cash flow. At the same time, the emphasis on product driven gains in key regions and support for its distributor base gives investors additional context for assessing whether the current share price and recent volatility align with their risk appetite.
Stay updated on the most important news stories for Herbalife by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Herbalife.
The refinancing plan puts Herbalife’s balance sheet in focus. The company is targeting US$1.55b of secured financing, including a US$425m revolving credit facility and a mix of Term Loan A, Term Loan B and other secured debt. With US$370m outstanding on the current Term Loan B as of 31 December 2025, extending the maturity profile could reduce near term refinancing pressure and give management more room to prioritize product launches and distributor support. However, the mix, pricing and covenants on the new facilities are not yet disclosed, so it is not clear how interest costs or leverage metrics will look after completion, if it occurs. Against this, Herbalife’s 2025 results show relatively stable sales at US$5,037.5m versus US$4,993.1m a year earlier, but lower net income of US$228.3m versus US$254.3m. That combination, along with existing risk flags around negative shareholders’ equity and interest coverage, means some investors are likely to focus on whether the refinancing meaningfully improves financial flexibility or mainly reshuffles existing obligations.
Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Herbalife to help decide what it's worth to you.
From here, the key points to watch are the final size, pricing and mix of the US$1.55b secured package and whether the company extends maturities without taking on materially higher interest costs. Investors may also look at how cash flow from Herbalife’s product driven momentum, including regions like India, compares with upcoming interest and principal commitments. Any updates to risk indicators around equity levels or interest coverage will be useful for assessing balance sheet strength versus global competitors such as Nu Skin, Tupperware or Amway related entities. Guidance for 2026 already points to low to mid single digit net sales growth ranges, so execution against that backdrop, alongside progress on product launches, will help show whether the refinancing is a stepping stone to a more resilient capital structure.
To ensure you're always in the loop on how the latest news impacts the investment narrative for Herbalife, head to the community page for Herbalife to never miss an update on the top community narratives.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com